United Services Automobile Association Blueprint Medicines Corp Transaction History

United Services Automobile Association

  • $3.88 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$72.9 - $101.41 $566,433 - $787,955
-7,770 Closed
0 $0
Q2 2019

Aug 16, 2019
BUY
$73.54 - $97.8 $88,836 - $118,142
1,208 Added 18.41%
7,770 $733,000
Q3 2018

Nov 13, 2018
BUY
$58.91 - $78.32 $1,354 - $1,801
23 Added 0.35%
6,562 $512,000
Q2 2018

Aug 10, 2018
BUY
$60.96 - $101.18 $15,179 - $25,193
249 Added 3.96%
6,539 $415,000
Q1 2018

May 14, 2018
BUY
$73.28 - $102.95 $460,931 - $647,555
6,290 New
6,290 $577,000

Others Institutions Holding BPMC

# of Institutions
352
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.68B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email